|
1
|
Ronco C, Bellomo R and Kellum JS: Acute
kidney injury. Lancet. 394:1949–1964. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fu Y and Dong Z: Immune response in
COVID-19-associated acute kidney injury and maladaptive kidney
repair. Integrative Medicine in Nephrology and Andrology.
10:e000222023. View Article : Google Scholar
|
|
3
|
Hoste EAJ, Kellum JA, Selby NM, Zarbock A,
Palevsky PM, Bagshaw SM, Goldstein SL, Cerdá J and Chawla LS:
Global epidemiology and outcomes of acute kidney injury. Nat Rev
Nephrol. 14:607–625. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Meena J, Kumar J, Kocharlakota JP, Gupta
H, Mittal P, Kumar A, Sinha A, Hari P and Bagga A: Acute kidney
injury in neonates: A meta-analysis. Pediatrics.
154:e20230651822024. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gautam SC, Lim J and Jaar BG:
Complications associated with continuous RRT. Kidney360.
3:1980–1990. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang R, Widdop RE and Ricardo SD:
Transition from acute kidney injury to chronic kidney disease:
Mechanisms, models, and biomarkers. Am J Physiol Renal Physiol.
327:F788–F805. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li J, Duan J, Hua C, Pan S, Li G, Feng Q,
Liu D and Liu Z: Nanomedicine embraces the treatment and prevention
of acute kidney injury to chronic kidney disease transition:
Evidence, challenges, and opportunities. Burns Trauma.
12:tkae0442024. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Koh ES and Chung S: Recent update on acute
kidney injury-to-chronic kidney disease transition. Yonsei Med J.
65:247–256. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Song Z and Gong X: Research progress on
the potential mechanisms of acute kidney injury and chronic kidney
disease induced by proton pump inhibitors. Integrative Medicine in
Nephrology and Andrology. 10:2023. View Article : Google Scholar
|
|
10
|
Stanski NL, Rodrigues CE, Strader M,
Murray PT, Endre ZH and Bagshaw SM: Precision management of acute
kidney injury in the intensive care unit: Current state of the art.
Intensive Care Med. 49:1049–1061. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Krishnasamy S, Sinha A and Bagga A:
Management of acute kidney injury in critically Ill children.
Indian J Pediatr. 90:481–491. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kou M, Huang L, Yang J, Chiang Z, Chen S,
Liu J, Guo L, Zhang X, Zhou X, Xu X, et al: Mesenchymal stem
cell-derived extracellular vesicles for immunomodulation and
regeneration: A next generation therapeutic tool? Cell Death Dis.
13:5802022. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Allinson CS, Pollock CA and Chen X:
Mesenchymal stem cells in the treatment of acute kidney injury
(AKI), chronic kidney disease (CKD) and the AKI-to-CKD transition.
Integrative Medicine in Nephrology and Andrology. 10:e000142023.
View Article : Google Scholar
|
|
14
|
Sávio-Silva C, Soinski-Sousa PE,
Balby-Rocha MTA, Lira ÁO and Rangel ÉB: Mesenchymal stem cell
therapy in acute kidney injury (AKI): Review and perspectives. Rev
Assoc Med Bras (1992). 13(66 Suppl 1): S45–S54. 2020. View Article : Google Scholar
|
|
15
|
Lee PW, Wu BS, Yang CY and Lee OK:
Molecular mechanisms of mesenchymal stem cell-based therapy in
acute kidney injury. Int J Mol Sci. 22:114062021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Khubutiya MS, Vagabov AV, Temnov AA and
Sklifas AN: Paracrine mechanisms of proliferative, anti-apoptotic
and anti-inflammatory effects of mesenchymal stromal cells in
models of acute organ injury. Cytotherapy. 16:579–585. 2014.
View Article : Google Scholar
|
|
17
|
Han Q, Wang X, Ding X, He J, Cai G and Zhu
H: Immunomodulatory effects of mesenchymal stem cells on
drug-induced acute kidney injury. Front Immunol. 12:6830032021.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fazekas B and Griffin MD: Mesenchymal
stromal cell-based therapies for acute kidney injury: Progress in
the last decade. Kidney Int. 97:1130–1140. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao L, Hu C, Han F, Wang J and Chen J:
Regenerative abilities of mesenchymal stem cells via acting as an
ideal vehicle for subcellular component delivery in acute kidney
injury. J Cell Mol Med. 24:4882–4891. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Birtwistle L, Chen XM and Pollock C:
Mesenchymal stem cell-derived extracellular vesicles to the rescue
of renal injury. Int J Mol Sci. 22:65962021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mukkala AN, Jerkic M, Khan Z, Szaszi K,
Kapus A and Rotstein O: Therapeutic effects of mesenchymal stromal
cells require mitochondrial transfer and quality control. Int J Mol
Sci. 24:157882023. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jiang D, Chen FX, Zhou H, Lu YY, Tan H, Yu
SJ, Yuan J, Liu H, Meng W and Jin ZB: Bioenergetic Crosstalk
between mesenchymal stem cells and various ocular cells through the
intercellular trafficking of mitochondria. Theranostics.
10:7260–7272. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Paliwal S, Chaudhuri R, Agrawal A and
Mohanty S: Regenerative abilities of mesenchymal stem cells through
mitochondrial transfer. J Biomed Sci. 25:312018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Michaeloudes C, Li X, Mak JCW and Bhavsar
PK: Study of mesenchymal stem cell-mediated mitochondrial transfer
in in vitro models of oxidant-mediated airway epithelial and smooth
muscle cell injury. Methods Mol Biol. 2269:93–105. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Iorio R, Petricca S, Mattei V and Monache
SD: Horizontal mitochondrial transfer as a novel bioenergetic tool
for mesenchymal stromal/stem cells: Molecular mechanisms and
therapeutic potential in a variety of diseases. J Transl Med.
22:4912024. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao L, Hu C, Zhang P, Jiang H and Chen J:
Preconditioning strategies for improving the survival rate and
paracrine ability of mesenchymal stem cells in acute kidney injury.
J Cell Mol Med. 23:720–730. 2019. View Article : Google Scholar :
|
|
27
|
Zhao L, Hu C, Zhang P, Jiang H and Chen J:
Novel preconditioning strategies for enhancing the migratory
ability of mesenchymal stem cells in acute kidney injury. Stem Cell
Res Ther. 9:2252018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Makkar D, Gakhar D, Mishra V and Rakha A:
Fine tuning mesenchymal stromal cells-code for mitigating kidney
diseases. Stem Cell Rev Rep. 20:738–754. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fu Z, Zhang Y, Geng X, Chi K, Liu C, Song
C, Cai G, Chen X and Hong Q: Optimization strategies of mesenchymal
stem cell-based therapy for acute kidney injury. Stem Cell Res
Ther. 14:1162023. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang Y, Lee EH and Yang Z:
Hypoxia-conditioned mesenchymal stem cells in tissue regeneration
application. Tissue Eng Part B Rev. 28:966–977. 2022. View Article : Google Scholar
|
|
31
|
Yasan GT and Gunel-Ozcan A: Hypoxia and
hypoxia mimetic agents as potential priming approaches to empower
mesenchymal stem cells. Curr Stem Cell Res Ther. 19:33–54. 2024.
View Article : Google Scholar
|
|
32
|
Li H, Ji XQ, Zhang SM and Bi RH: Hypoxia
and inflammatory factor preconditioning enhances the
immunosuppressive properties of human umbilical cord mesenchymal
stem cells. World J Stem Cells. 15:999–1016. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Muscari C, Giordano E, Bonafè F, Govoni M,
Pasini A and Guarnieri C: Priming adult stem cells by hypoxic
pretreatments for applications in regenerative medicine. J Biomed
Sci. 20:632013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang W, Liu L, Huo Y, Yang Y and Wang Y:
Hypoxia-pretreated human MSCs attenuate acute kidney injury through
enhanced angiogenic and antioxidative capacities. Biomed Res Int.
2014:4624722014.PubMed/NCBI
|
|
35
|
Collino F, Lopes JA, Corrêa S, Abdelhay E,
Takiya CM, Wendt CHC, de Miranda KR, Vieyra A and Lindoso R:
Adipose-derived mesenchymal stromal cells under hypoxia: Changes in
extracellular vesicles secretion and improvement of renal recovery
after ischemic injury. Cell Physiol Biochem. 52:1463–1483.
2019.PubMed/NCBI
|
|
36
|
Jang MJ, You D, Park JY, Kim K, Aum J, Lee
C, Song G, Shin HC, Suh N, Kim YM and Kim CS: Hypoxic
preconditioned mesenchymal stromal cell therapy in a rat model of
renal ischemia-reperfusion injury: development of optimal protocol
to potentiate therapeutic efficacy. Int J Stem Cells. 11:157–167.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Putra A, Pertiwi D, Milla MN, Indrayani
UD, Jannah D, Sahariyani M, Trisnadi S and Wibowo JW:
Hypoxia-preconditioned MSCs have superior effect in ameliorating
renal function on acute renal failure animal model. Open Access
Maced J Med Sci. 7:305–310. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yuan F, Liu J, Zhong L, Liu P, Li T, Yang
K, Gao W, Zhang G, Sun J and Zou X: Enhanced therapeutic effects of
hypoxia-preconditioned mesenchymal stromal cell-derived
extracellular vesicles in renal ischemic injury. Stem Cell Res
Ther. 16:392025. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Overath JM, Gauer S, Obermüller N,
Schubert R, Schäfer R, Geiger H and Baer PC: Short-term
preconditioning enhances the therapeutic potential of
adipose-derived stromal/stem cell-conditioned medium in
cisplatin-induced acute kidney injury. Exp Cell Res. 342:175–183.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yu X, Lu C, Liu H, Rao S, Cai J, Liu S,
Kriegel AJ, Greene AS, Liang M and Ding X: Hypoxic preconditioning
with cobalt of bone marrow mesenchymal stem cells improves cell
migration and enhances therapy for treatment of ischemic acute
kidney injury. PLoS One. 8:e627032013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Tseng WC, Lee PY, Tsai MT, Chang FP, Chen
NJ, Chien CT, Hung SC and Tarng DC: Hypoxic mesenchymal stem cells
ameliorate acute kidney ischemia-reperfusion injury via enhancing
renal tubular autophagy. Stem Cell Res Ther. 12:3672021. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu P, Feng Y, Dong C, Liu D, Wu X, Wu H,
Lv P and Zhou Y: Study on therapeutic action of bone marrow derived
mesenchymal stem cell combined with vitamin E against acute kidney
injury in rats. Life Sci. 92:829–837. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Guo Q and Wang J: Effect of combination of
vitamin E and umbilical cord-derived mesenchymal stem cells on
inflammation in mice with acute kidney injury. Immunopharmacol
Immunotoxicol. 40:168–172. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Deng L, Li H, Su X, Zhang Y, Xu H, Fan L,
Fan J, Han Q, Bai X and Zhao RC: Chlorzoxazone, a small molecule
drug, augments immunosuppressive capacity of mesenchymal stem cells
via modulation of FOXO3 phosphorylation. Cell Death Dis.
11:1582020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Cai J, Yu X, Zhang B, Zhang H, Fang Y, Liu
S, Liu T and Ding X: Atorvastatin improves survival of implanted
stem cells in a rat model of renal ischemia-reperfusion injury. Am
J Nephrol. 39:466–475. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Altun B, Yilmaz R, Aki T, Akoglu H, Zeybek
D, Piskinpasa S, Uckan D, Purali N, Korkusuz P and Turgan C: Use of
mesenchymal stem cells and darbepoetin improve ischemia-induced
acute kidney injury outcomes. Am J Nephrol. 35:531–539. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
LiverTox: Clinical and Research
Information on Drug-Induced Liver Injury (Internet). National
Institute of Diabetes and Digestive and Kidney Diseases; Bethesda,
MD: 2012, https://www.ncbi.nlm.nih.gov/books/NBK548137/.
|
|
48
|
Dh HS, Sultana R, Prabhu A, Pavan SR,
Mohanto S and Subramaniyan V: Biomedicine and pharmacotherapeutic
effectiveness of combinatorial atorvastatin and quercetin on
diabetic nephropathy: An in vitro study. Biomed Pharmacother.
174:1165332024. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Qu H, Xu H, Tian Y and Jiang X:
Atorvastatin improves microenvironment to enhance the beneficial
effects of BMSCs therapy in a rabbit model of acute myocardial
infarction. Cell Physiol Biochem. 32:380–389. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wu Y and Yang B: Erythropoietin Receptor/β
common receptor: A shining light on acute kidney injury induced by
ischemia-reperfusion. Front Immunol. 12:6977962021. View Article : Google Scholar
|
|
51
|
Ghassemi-Barghi N, Ehsanfar Z,
Mohammadrezakhani O, Ashari S, Ghiabi S and Bayrami Z: Mechanistic
approach for protective effect of ARA290, a specific ligand for the
erythropoietin/CD131 heteroreceptor, against cisplatin-induced
nephrotoxicity, the involvement of apoptosis and inflammation
pathways. Inflammation. 46:342–358. 2023. View Article : Google Scholar
|
|
52
|
Johnson DW, Pat B, Vesey DA, Guan Z, Endre
Z and Gobe GC: Delayed administration of darbepoetin or
erythropoietin protects against ischemic acute renal injury and
failure. Kidney Int. 69:1806–1813. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Hakiminia B, Goudarzi A and Moghaddas A:
Has vitamin E any shreds of evidence in cisplatin-induced toxicity.
J Biochem Mol Toxicol. 33:e223492019. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Darwish MA, Abo-Youssef AM, Khalaf MM,
Abo-Saif AA, Saleh IG and Abdelghany TM: Vitamin E mitigates
cisplatin-induced nephrotoxicity due to reversal of
oxidative/nitrosative stress, suppression of inflammation and
reduction of total renal platinum accumulation. J Biochem Mol
Toxicol. 31:1–9. 2017. View Article : Google Scholar
|
|
55
|
Abo-Elmaaty AMA, Behairy A, El-Naseery NI
and Abdel-Daim MM: The protective efficacy of vitamin E and cod
liver oil against cisplatin-induced acute kidney injury in rats.
Environ Sci Pollut Res Int. 27:44412–44426. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Kim H, Yu MR, Lee H, Kwon SH, Jeon JS, Han
DC and Noh H: Metformin inhibits chronic kidney disease-induced DNA
damage and senescence of mesenchymal stem cells. Aging Cell.
20:e133172021. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Hu Q, Zhu B, Yang G, Jia J, Wang H, Tan R,
Zhang Q, Wang L and Kantawong F: Calycosin pretreatment enhanced
the therapeutic efficacy of mesenchymal stem cells to alleviate
unilateral ureteral obstruction-induced renal fibrosis by
inhibiting necroptosis. J Pharmacol Sci. 151:72–83. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Jiang W and Xu J: Immune modulation by
mesenchymal stem cells. Cell Prolif. 53:e127122020. View Article : Google Scholar :
|
|
59
|
Huang Y, Wu Q and Tam PKH:
Immunomodulatory mechanisms of mesenchymal stem cells and their
potential clinical applications. Int J Mol Sci. 23:100232022.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Zhou J and Shi Y: Mesenchymal stem/stromal
cells (MSCs): Origin, immune regulation, and clinical applications.
Cell Mol Immunol. 20:555–557. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Wang Y, Fang J, Liu B, Shao C and Shi Y:
Reciprocal regulation of mesenchymal stem cells and immune
responses. Cell Stem Cell. 29:1515–1530. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Li P, Ou Q, Shi S and Shao C:
Immunomodulatory properties of mesenchymal stem cells/dental stem
cells and their therapeutic applications. Cell Mol Immunol.
20:558–569. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Wang S, Umrath F, Cen W, Salgado AJ,
Reinert S and Alexander D: Pre-conditioning with IFN-γ and hypoxia
enhances the angiogenic potential of iPSC-Derived MSC secretome.
Cells. 11:9882022. View Article : Google Scholar
|
|
64
|
Wu J, Wu J, Xiang W, Gong Y, Feng D, Fang
S, Wu Y, Liu Z, Li Y, Chen R, et al: Engineering exosomes derived
from TNF-α preconditioned IPFP-MSCs enhance both yield and
therapeutic efficacy for osteoarthritis. J Nanobiotechnology.
22:5552024. View Article : Google Scholar
|
|
65
|
Nakao Y, Fukuda T, Zhang Q, Sanui T,
Shinjo T, Kou X, Chen C, Liu D, Watanabe Y, Hayashi C, et al:
Exosomes from TNF-α-treated human gingiva-derived MSCs enhance M2
macrophage polarization and inhibit periodontal bone loss. Acta
Biomater. 122:306–324. 2021. View Article : Google Scholar
|
|
66
|
Ma T, Wang X, Jiao Y, Wang H, Qi Y, Gong
H, Zhang L and Jiang D: Interleukin 17 (IL-17)-induced mesenchymal
stem cells prolong the survival of allogeneic skin grafts. Ann
Transplant. 23:615–621. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Zhao C, Li J, Cai H, Wu D, Tao S, Pi C,
Zhu L, Xu N and Zhang T: An injectable hydrogel scaffold with
IL-1β-activated MSC-derived exosomes for the treatment of
endometritis. Biomater Sci. 11:1422–1436. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Pezzanite LM, Chow L, Phillips J,
Griffenhagen GM, Moore AR, Schaer TP, Engiles JB, Werpy N,
Gilbertie J, Schnabel LV, et al: TLR-activated mesenchymal stromal
cell therapy and antibiotics to treat multi-drug resistant
Staphylococcal septic arthritis in an equine model. Ann Transl Med.
10:11572022. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Giuliani M, Bennaceur-Griscelli A,
Nanbakhsh A, Oudrhiri N, Chouaib S, Azzarone B, Durrbach A and
Lataillade JJ: TLR ligands stimulation protects MSC from NK
killing. Stem Cells. 32:290–300. 2014. View Article : Google Scholar
|
|
70
|
Kwon YW, Heo SC, Jeong GO, Yoon JW, Mo WM,
Lee MJ, Jang IH, Kwon SM, Lee JS and Kim JH: Tumor necrosis
factor-α-activated mesenchymal stem cells promote endothelial
progenitor cell homing and angiogenesis. Biochim Biophys Acta.
1832:2136–2144. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Heo SC, Jeon ES, Lee IH, Kim HS, Kim MB
and Kim JH: Tumor necrosis factor-α-activated human adipose
tissue-derived mesenchymal stem cells accelerate cutaneous wound
healing through paracrine mechanisms. J Invest Dermatol.
131:1559–1567. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Bai X, Xi J, Bi Y, Zhao X, Bing W, Meng X,
Liu Y, Zhu Z and Song G: TNF-alpha promotes survival and migration
of MSCs under oxidative stress via NF-κB pathway to attenuate
intimal hyperplasia in vein grafts. J Cell Mol Med. 21:2077–2091.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Zhao L, Hu C, Zhang P, Jiang H and Chen J:
Melatonin preconditioning is an effective strategy for mesenchymal
stem cell-based therapy for kidney disease. J Cell Mol Med.
24:25–33. 2020. View Article : Google Scholar
|
|
74
|
Alzahrani FA: Melatonin improves
therapeutic potential of mesenchymal stem cells-derived exosomes
against renal ischemia-reperfusion injury in rats. Am J Transl Res.
11:2887–2907. 2019.PubMed/NCBI
|
|
75
|
Aussel C, Baudry N, Grosbot M, Caron C,
Vicaut E, Banzet S and Peltzer JS: IL-1β primed mesenchymal stromal
cells moderate hemorrhagic shock-induced organ injuries. Stem Cell
Res Ther. 12:4382021. View Article : Google Scholar
|
|
76
|
Bai M, Zhang L, Fu B, Bai J, Zhang Y, Cai
G, Bai X, Feng Z, Sun S and Chen X: IL-17A improves the efficacy of
mesenchymal stem cells in ischemic-reperfusion renal injury by
increasing Treg percentages by the COX-2/PGE2 pathway. Kidney Int.
93:814–825. 2018. View Article : Google Scholar
|
|
77
|
Chen HH, Lin KC, Wallace CG, Chen YT, Yang
CC, Leu S, Chen YC, Sun CK, Tsai TH, Chen YL, et al: Additional
benefit of combined therapy with melatonin and apoptotic
adipose-derived mesenchymal stem cell against sepsis-induced kidney
injury. J Pineal Res. 57:16–32. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Kanai R, Nakashima A, Doi S, Kimura T,
Yoshida K, Maeda S, Ishiuchi N, Yamada Y, Ike T, Doi T, et al:
Interferon-gamma enhances the therapeutic effect of mesenchymal
stem cells on experimental renal fibrosis. Sci Rep. 11:8502021.
View Article : Google Scholar
|
|
79
|
Mias C, Trouche E, Seguelas MH, Calcagno
F, Dignat-George F, Sabatier F, Piercecchi-Marti MD, Daniel L,
Bianchi P, Calise D, et al: Ex vivo pretreatment with melatonin
improves survival, proangiogenic/mitogenic activity, and efficiency
of mesenchymal stem cells injected into ischemic kidney. Stem
Cells. 26:1749–1757. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Zhao J, Young YK, Fradette J and
Eliopoulos N: Melatonin pretreatment of human adipose
tissue-derived mesenchymal stromal cells enhances their prosurvival
and protective effects on human kidney cells. Am J Physiol Renal
Physiol. 308:F1474–F1483. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Zhou S, Qiao YM, Liu YG, Liu D, Hu JM,
Liao J, Li M, Guo Y, Fan LP, Li LY and Zhao M: Bone marrow derived
mesenchymal stem cells pretreated with erythropoietin accelerate
the repair of acute kidney injury. Cell Biosci. 10:1302020.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Wang S, Wang G, Zhang L, Li F, Liu K, Wang
Y, Shi Y and Cao K: Interleukin-17 promotes nitric oxide-dependent
expression of PD-L1 in mesenchymal stem cells. Cell Biosci.
10:732020. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Han X, Yang Q, Lin L, Xu C, Zheng C, Chen
X, Han Y, Li M, Cao W, Cao K, et al: Interleukin-17 enhances
immunosuppression by mesenchymal stem cells. Cell Death Differ.
21:1758–1768. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Wang C, Jiang C, Yang Y, Xi C, Yin Y, Wu H
and Qian C: Therapeutic potential of HUC-MSC-exos primed with IFN-γ
against LPS-induced acute lung injury. Iran J Basic Med Sci.
27:375–382. 2024.
|
|
85
|
Stazi M, Negro S, Megighian A, D'Este G,
Solimena M, Jockers R, Lista F, Montecucco C and Rigoni M:
Melatonin promotes regeneration of injured motor axons via
MT1 receptors. J Pineal Res. 70:e126952021. View Article : Google Scholar
|
|
86
|
Romero A, Morales-Garcia JA and Ramos E:
Melatonin: A multitasking indoleamine to modulate hippocampal
neurogenesis. Neural Regen Res. 18:503–505. 2023. View Article : Google Scholar
|
|
87
|
Reiter RJ, Tan DX, Poeggeler B,
Menendez-Pelaez A, Chen LD and Saarela S: Melatonin as a free
radical scavenger: Implications for aging and age-related diseases.
Ann N Y Acad Sci. 719:1–12. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Reiter RJ, Tan DX and Fuentes-Broto L:
Melatonin: A multitasking molecule. Prog Brain Res. 181:127–151.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Reiter RJ: Melatonin: The chemical
expression of darkness. Mol Cell Endocrinol. 79:C153–C158. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Feng ZY, Yang SD, Wang T and Guo S: Effect
of melatonin for regulating mesenchymal stromal cells and derived
extracellular vesicles. Front Cell Dev Biol. 9:7179132021.
View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Elzainy A, El Sadik A and Altowayan WM:
Comparison between the regenerative and therapeutic impacts of bone
marrow mesenchymal stem cells and adipose mesenchymal stem cells
pre-treated with melatonin on liver fibrosis. Biomolecules.
14:2972024. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Zou D, Liao J, Xiao M, Liu L and Xu M:
Melatonin alleviates hyperoxia-induced lung injury through
elevating MSC exosomal miR-18a-5p expression to repress PUM2
signaling. FASEB J. 38:e700122024. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Rafiq H, Ayaz M, Khan HA, Iqbal M, Quraish
S, Afridi SG, Khan A, Khan B, Sher A, Siraj F and Shams S:
Therapeutic potential of stem cell and melatonin on the reduction
of CCl4-induced liver fibrosis in experimental mice model. Braz J
Biol. 84:e2530612022. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Mintoft A, Vallatos A and Robertson NJ:
Mesenchymal stromal cell therapy for hypoxic ischemic
encephalopathy: Future directions for combination therapy with
hypothermia and/or melatonin. Semin Perinatol. 48:1519292024.
View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Lee JH, Han YS and Lee SH:
Melatonin-induced PGC-1α improves angiogenic potential of
mesenchymal stem cells in hindlimb ischemia. Biomol Ther (Seoul).
28:240–249. 2020. View Article : Google Scholar
|
|
96
|
Hanna M, Elnassag SS, Mohamed DH, Elbaset
MA, Shaker O, Khowailed EA and Gouda SAA: Melatonin and mesenchymal
stem cells co-administration alleviates chronic obstructive
pulmonary disease via modulation of angiogenesis at the
vascular-alveolar unit. Pflugers Arch. 476:1155–1168. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Tripathy S and Bhattamisra SK: Cellular
signalling of melatonin and its role in metabolic disorders. Mol
Biol Rep. 52:1932025. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Slominski RM, Reiter RJ,
Schlabritz-Loutsevitch N, Ostrom RS and Slominski AT: Melatonin
membrane receptors in peripheral tissues: Distribution and
functions. Mol Cell Endocrinol. 351:152–166. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Charif SE and Dorfman VB: Melatonin,
modulation of hypothalamic activity, and reproduction. Vitam Horm.
127:283–303. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Saberi K, Pasbakhsh P, Omidi A,
Borhani-Haghighi M, Nekoonam S, Omidi N, Ghasemi S and Kashani IR:
Melatonin preconditioning of bone marrow-derived mesenchymal stem
cells promotes their engraftment and improves renal regeneration in
a rat model of chronic kidney disease. J Mol Histol. 50:129–140.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Yasuoka Y, Izumi Y, Fukuyama T, Oshima T,
Yamazaki T, Uematsu T, Kobayashi N, Nanami M, Shimada Y, Nagaba Y,
et al: Tubular endogenous erythropoietin protects renal function
against ischemic reperfusion injury. Int J Mol Sci. 25:12232024.
View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Bi B, Guo J, Marlier A, Lin SR and Cantley
LG: Erythropoietin expands a stromal cell population that can
mediate renoprotection. Am J Physiol Renal Physiol.
295:F1017–F1022. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Zuo L, Li DD, Ma XX, Shi SH, Lyu DC, Shen
J, Zhang WF, Gao EH and Cao JM: Erythropoietin promotes myocardial
infarction repair in mice by improving the function of Sca-1(+)
stem cells. Sheng Li Xue Bao. 75:36–48. 2023.PubMed/NCBI
|
|
104
|
Wu YW, Comstock BA, Gonzalez FF, Mayock
DE, Goodman AM, Maitre NL, Chang T, Van Meurs KP, Lampland AL,
Bendel-Stenzel E, et al: Trial of erythropoietin for
hypoxic-ischemic encephalopathy in newborns. N Engl J Med.
387:148–159. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Bianchi VE and von Haehling S: The
treatment of chronic anemia in heart failure: A global approach.
Clin Res Cardiol. 113:1117–1136. 2024. View Article : Google Scholar
|
|
106
|
Jun JH, Jun NH, Shim JK, Shin EJ and Kwak
YL: Erythropoietin protects myocardium against ischemia-reperfusion
injury under moderate hyperglycemia. Eur J Pharmacol. 745:1–9.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Zhou S, Liu YG, Zhang Y, Hu JM, Liu D,
Chen H, Li M, Guo Y, Fan LP, Li LY and Zhao M: Bone mesenchymal
stem cells pretreated with erythropoietin enhance the effect to
ameliorate cyclosporine A-induced nephrotoxicity in rats. J Cell
Biochem. 119:8220–8232. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Verdino P, Lee SL, Cooper FN, Cottle SR,
Grealish PF, Hu CC, Meyer CM, Lin J, Copeland V, Porter G, et al:
Development of a long-acting relaxin analogue, LY3540378, for
treatment of chronic heart failure. Br J Pharmacol. 180:1965–1980.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Samuel CS and Hewitson TD: Relaxin in
cardiovascular and renal disease. Kidney Int. 69:1498–1502. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Martins RC, Pintalhao M, Leite-Moreira A
and Castro-Chaves P: Relaxin and the cardiovascular system: From
basic science to clinical practice. Curr Mol Med. 20:167–184. 2020.
View Article : Google Scholar
|
|
111
|
Feiteng C, Lei C, Deng L, Chaoliang X,
Zijie X, Yi S and Minglei S: Relaxin inhibits renal fibrosis and
the epithelial-to-mesenchymal transition via the Wnt/beta-catenin
signaling pathway. Ren Fail. 44:513–524. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Conrad KP, von Versen-Hoynck F and Baker
VL: Potential role of the corpus luteum in maternal cardiovascular
adaptation to pregnancy and preeclampsia risk. Am J Obstet Gynecol.
226:683–699. 2022. View Article : Google Scholar
|
|
113
|
Bathgate RA, Ivell R, Sanborn BM, Sherwood
OD and Summers RJ: International union of pharmacology LVII:
Recommendations for the nomenclature of receptors for relaxin
family peptides. Pharmacol Rev. 58:7–31. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Li Y, Shen M, Ferens D, Broughton BRS,
Murthi P, Saini S, Widdop RE, Ricardo SD, Pinar AA and Samuel CS:
Combining mesenchymal stem cells with serelaxin provides enhanced
renoprotection against 1K/DOCA/salt-induced hypertension. Br J
Pharmacol. 178:1164–1181. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Li H, Lu W, Wang A, Jiang H and Lyu J:
Changing epidemiology of chronic kidney disease as a result of type
2 diabetes mellitus from 1990 to 2017: Estimates from global burden
of disease 2017. J Diabetes Investig. 12:346–356. 2021. View Article : Google Scholar
|
|
116
|
Huuskes BM, Wise AF, Cox AJ, Lim EX, Payne
NL, Kelly DJ, Samuel CS and Ricardo SD: Combination therapy of
mesenchymal stem cells and serelaxin effectively attenuates renal
fibrosis in obstructive nephropathy. FASEB J. 29:540–553. 2015.
View Article : Google Scholar
|
|
117
|
Badawi A, Jefferson OC, Huuskes BM,
Ricardo SD, Kerr PG, Samuel CS and Murthi P: A novel approach to
enhance the regenerative potential of circulating endothelial
progenitor cells in patients with end-stage kidney disease.
Biomedicines. 10:8832022. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Feng G, Zhang J, Li Y, Nie Y, Zhu D, Wang
R, Liu J, Gao J, Liu N, He N, et al: IGF-1 C domain-modified
hydrogel enhances cell therapy for AKI. J Am Soc Nephrol.
27:2357–2369. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Fu Z, Chu Y, Geng X, Ma Y, Chi K, Song C,
Liao S, Hong Q, Wu D and Wang Y: Artificial kidney capsule packed
with mesenchymal stem cell-laden hydrogel for the treatment of
rhabdomyolysis-induced acute kidney injury. ACS Biomater Sci Eng.
8:1726–1734. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Geng X, Hong Q, Wang W, Zheng W, Li O, Cai
G, Chen X and Wu D: Biological membrane-packed mesenchymal stem
cells treat acute kidney disease by ameliorating
mitochondrial-related apoptosis. Sci Rep. 7:411362017. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Han DS, Erickson C, Hansen KC,
Kirkbride-Romeo L, He Z, Rodell CB and Soranno DE: Mesenchymal stem
cells delivered locally to ischemia-reperfused kidneys via
injectable hyaluronic acid hydrogels decrease extracellular matrix
remodeling 1 month after injury in male mice. Cells. 12:17712023.
View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Huang S, Li Y, Wang X, Ma X and Zhang X:
Injectable co-gels of collagen and decellularized vascular matrix
improve MSC-based therapy for acute kidney injury. J Biomater Sci
Polym Ed. 28:2186–2195. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Najafi H, Abolmaali SS, Heidari R,
Valizadeh H, Tamaddon AM and Azarpira N: Integrin receptor-binding
nanofibrous peptide hydrogel for combined mesenchymal stem cell
therapy and nitric oxide delivery in renal ischemia/reperfusion
injury. Stem Cell Res Ther. 13:3442022. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Xu Y, Shi T, Xu A and Zhang L: 3D spheroid
culture enhances survival and therapeutic capacities of MSCs
injected into ischemic kidney. J Cell Mol Med. 20:1203–1213. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Wang H, Shang Y, Chen X, Wang Z, Zhu D,
Liu Y, Zhang C, Chen P, Wu J, Wu L, et al: Delivery of MSCs with a
hybrid beta-sheet peptide hydrogel consisting IGF-1C domain and
D-Form peptide for acute kidney injury therapy. Int J Nanomedicine.
15:4311–4324. 2020. View Article : Google Scholar :
|
|
126
|
Ho TC, Chang CC, Chan HP, Chung TW, Shu
CW, Chuang KP, Duh TH, Yang MH and Tyan YC: Hydrogels: Properties
and applications in biomedicine. Molecules. 27:29022022. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Hameed H, Faheem S, Paiva-Santos AC,
Sarwar HS and Jamshaid M: A Comprehensive review of hydrogel-based
drug delivery systems: classification, properties, recent trends,
and applications. AAPS PharmSciTech. 25:642024. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Seliktar D: Designing cell-compatible
hydrogels for biomedical applications. Science. 336:1124–1128.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Yap JX, Leo CP, Yasin NH, Show PL, Chu DT,
Singh V and Derek CJC: Recent advances of natural biopolymeric
culture scaffold: Synthesis and modification. Bioengineered.
13:2226–2247. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Wechsler ME, Rao VV, Borelli AN and Anseth
KS: Engineering the MSC Secretome: A hydrogel focused approach. Adv
Healthc Mater. 10:e20019482021. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Peng J, Yang T, Chen S, Deng N, Luo X,
Liao R and Su B: Utilization of hydrogels in mesenchymal stem
cell-based therapy for kidney diseases. Tissue Eng Part B Rev.
30:315–326. 2024. View Article : Google Scholar
|
|
132
|
Zhao L, Zhou Y, Zhang J, Liang H, Chen X
and Tan H: Natural polymer-based hydrogels: From polymer to
biomedical applications. Pharmaceutics. 15:25142023. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Zhang M and Zhao X: Alginate hydrogel
dressings for advanced wound management. Int J Biol Macromol.
162:1414–1428. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Kou SG, Peters LM and Mucalo MR: Chitosan:
A review of sources and preparation methods. Int J Biol Macromol.
169:85–94. 2021. View Article : Google Scholar
|
|
135
|
Yazdi MK, Taghizadeh A, Taghizadeh M,
Stadler FJ, Farokhi M, Mottaghitalab F, Zarrintaj P, Ramsey JD,
Seidi F, Saeb MR and Mozafari M: Agarose-based biomaterials for
advanced drug delivery. J Control Release. 326:523–543. 2020.
View Article : Google Scholar
|
|
136
|
Burdick JA and Prestwich GD: Hyaluronic
acid hydrogels for biomedical applications. Adv Mater. 23:H41–H56.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Hu X, Xia Z and Cai K: Recent advances in
3D hydrogel culture systems for mesenchymal stem cell-based therapy
and cell behavior regulation. J Mater Chem B. 10:1486–1507. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Axpe E and Oyen ML: Applications of
alginate-based bioinks in 3D Bioprinting. Int J Mol Sci.
17:19762016. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Troy E, Tilbury MA, Power AM and Wall JG:
Nature-based biomaterials and their application in biomedicine.
Polymers (Basel). 13:33212021. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Lee KY and Mooney DJ: Alginate: Properties
and biomedical applications. Prog Polym Sci. 37:106–126. 2012.
View Article : Google Scholar
|
|
141
|
Khatab S, Leijs MJ, van Buul G, Haeck J,
Kops N, Nieboer M, Bos PK, Verhaar JAN, Bernsen M and van Osch
GJVM: MSC encapsulation in alginate microcapsules prolongs survival
after intra-articular injection, a longitudinal in vivo cell and
bead integrity tracking study. Cell Biol Toxicol. 36:553–570. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Mohammadi M, Luong JC, Rodriguez SM, Cao
R, Wheeler AE, Lau H, Li S, Shabestari SK, Chadarevian JP,
Alexander M, et al: Controlled release of stem cell secretome
attenuates inflammatory response against implanted biomaterials.
Adv Healthc Mater. 9:e19018742020. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Bari E, Scocozza F, Perteghella S, Sorlini
M, Auricchio F, Torre ML and Conti M: 3D bioprinted scaffolds
containing mesenchymal stem/stromal lyosecretome: Next generation
controlled release device for bone regenerative medicine.
Pharmaceutics. 13:5152021. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Huang Y, Onyeri S, Siewe M, Moshfeghian A
and Madihally SV: In vitro characterization of chitosan-gelatin
scaffolds for tissue engineering. Biomaterials. 26:7616–7627. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Wagenbrenner M, Mayer-Wagner S, Rudert M,
Holzapfel BM and Weissenberger M: Combinations of hydrogels and
mesenchymal stromal cells (MSCs) for cartilage tissue engineering-A
review of the literature. Gels. 7:2172021. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Gao J, Liu R, Wu J, Liu Z, Li J, Zhou J,
Hao T, Wang Y, Du Z, Duan C and Wang C: The use of chitosan based
hydrogel for enhancing the therapeutic benefits of adipose-derived
MSCs for acute kidney injury. Biomaterials. 33:3673–3681. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Lee CH, Singla A and Lee Y: Biomedical
applications of collagen. Int J Pharm. 221:1–22. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Huang M, Li D, Chen J, Ji Y, Su T, Chen Y,
Zhang Y, Wang Y, Li F, Chen S, et al: Comparison of the treatment
efficacy of umbilical mesenchymal stem cell transplantation via
renal subcapsular and parenchymal routes in AKI-CKD mice. Stem Cell
Res Ther. 13:1282022. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Huang Q, Zou Y, Arno MC, Chen S, Wang T,
Gao J, Dove AP and Du J: Hydrogel scaffolds for differentiation of
adipose-derived stem cells. Chem Soc Rev. 46:6255–6275. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
150
|
La Manna G, Bianchi F, Cappuccilli M,
Cenacchi G, Tarantino L, Pasquinelli G, Valente S, Della Bella E,
Cantoni S, Claudia C, et al: Mesenchymal stem cells in renal
function recovery after acute kidney injury: Use of a
differentiating agent in a rat model. Cell Transplant.
20:1193–1208. 2011. View Article : Google Scholar
|
|
151
|
Rohanizadeh R, Swain MV and Mason RS:
Gelatin sponges (Gelfoam) as a scaffold for osteoblasts. J Mater
Sci Mater Med. 19:1173–1182. 2008. View Article : Google Scholar
|
|
152
|
Bello AB, Kim D, Kim D, Park H and Lee SH:
Engineering and functionalization of gelatin biomaterials: From
cell culture to medical applications. Tissue Eng Part B Rev.
26:164–180. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Helminger M, Wu B, Kollmann T, Benke D,
Schwahn D, Pipich V, Faivre D, Zahn D and Cölfen H: Synthesis and
characterization of gelatin-based magnetic hydrogels. Adv Funct
Mater. 24:3187–3196. 2014. View Article : Google Scholar
|
|
154
|
Mushtaq F, Raza ZA, Batool SR, Zahid M,
Onder OC, Rafique A and Nazeer MA: Preparation, properties, and
applications of gelatin-based hydrogels (GHs) in the environmental,
technological, and biomedical sectors. Int J Biol Macromol.
218:601–633. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Sobreiro-Almeida R, Quinteira R and Neves
NM: Renal regeneration: The role of extracellular matrix and
current ECM-based tissue engineered strategies. Adv Healthc Mater.
10:e21001602021. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Song JJ, Guyette JP, Gilpin SE, Gonzalez
G, Vacanti JP and Ott HC: Regeneration and experimental orthotopic
transplantation of a bioengineered kidney. Nat Med. 19:646–651.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Kim JW, Nam SA, Yi J, Kim JY, Lee JY, Park
SY, Sen T, Choi YM, Lee JY, Kim HL, et al: Kidney decellularized
extracellular matrix enhanced the vascularization and maturation of
human kidney organoids. Adv Sci (Weinh). 9:e21035262022. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Saldin LT, Cramer MC, Velankar SS, White
LJ and Badylak SF: Extracellular matrix hydrogels from
decellularized tissues: Structure and function. Acta Biomater.
49:1–15. 2017. View Article : Google Scholar :
|
|
159
|
Zhou C, Zhou L, Liu J, Xu L, Xu Z, Chen Z,
Ge Y, Zhao F, Wu R, Wang X, et al: Kidney extracellular matrix
hydrogel enhances therapeutic potential of adipose-derived
mesenchymal stem cells for renal ischemia reperfusion injury. Acta
Biomater. 115:250–263. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Li J, Chee HL, Chong YT, Chan BQY, Xue K,
Lim PC, Loh XJ and Wang F: Hofmeister effect mediated strong
PHEMA-Gelatin hydrogel actuator. ACS Appl Mater Interfaces.
14:23826–23838. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Zullo JA, Nadel EP, Rabadi MM, Baskind MJ,
Rajdev MA, Demaree CM, Vasko R, Chugh SS, Lamba R, Goligorsky MS
and Ratliff BB: The secretome of hydrogel-coembedded endothelial
progenitor cells and mesenchymal stem cells instructs macrophage
polarization in endotoxemia. Stem Cells Transl Med. 4:852–861.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Tietze S, Kräter M, Jacobi A, Taubenberger
A, Herbig M, Wehner R, Schmitz M, Otto O, List C, Kaya B, et al:
Spheroid culture of mesenchymal stromal cells results in
morphorheological properties appropriate for improved
microcirculation. Adv Sci (Weinh). 6:18021042019. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Shoma Suresh K, Bhat S, Guru BR, Muttigi
MS and Seetharam RN: A nanocomposite hydrogel delivery system for
mesenchymal stromal cell secretome. Stem Cell Res Ther. 11:2052020.
View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Xu X, Jha AK, Harrington DA, Farach-Carson
MC and Jia X: Hyaluronic acid-based hydrogels: From a natural
polysaccharide to complex networks. Soft Matter. 8:3280–3294. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Kleinman HK and Martin GR: Matrigel:
Basement membrane matrix with biological activity. Semin Cancer
Biol. 15:378–386. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Goetzke R, Franzen J, Ostrowska A, Vogt M,
Blaeser A, Klein G, Rath B, Fischer H, Zenke M and Wagner W: Does
soft really matter? Differentiation of induced pluripotent stem
cells into mesenchymal stromal cells is not influenced by soft
hydrogels. Biomaterials. 156:147–158. 2018. View Article : Google Scholar
|
|
167
|
Najafi H, Abolmaali SS, Heidari R,
Valizadeh H, Jafari M, Tamaddon AM and Azarpira N: Nitric oxide
releasing nanofibrous Fmoc-dipeptide hydrogels for amelioration of
renal ischemia/reperfusion injury. J Control Release. 337:1–13.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Lin RZ and Chang HY: Chang, recent
advances in three-dimensional multicellular spheroid culture for
biomedical research. Biotechnol J. 3:1172–1184. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Ryu NE, Lee SH and Park H: Spheroid
culture system methods and applications for mesenchymal stem cells.
Cells. 8:16202019. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Yang WY, Chen LC, Jhuang YT, Lin YJ, Hung
PY, Ko YC, Tsai MY, Lee YW, Hsu LW, Yeh CK, et al: Injection of
hybrid 3D spheroids composed of podocytes, mesenchymal stem cells,
and vascular endothelial cells into the renal cortex improves
kidney function and replenishes glomerular podocytes. Bioeng Transl
Med. 6:e102122021. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Xu H, Chen C, Hu L and Hou J:
Gene-modified mesenchymal stem cell-based therapy in renal
ischemia-reperfusion injury. Curr Gene Ther. 17:453–460. 2017.
View Article : Google Scholar
|
|
172
|
Roudkenar MH, Halabian R, Tehrani HA,
Amiri F, Jahanian-Najafabadi A, Roushandeh AM, Abbasi-Malati Z and
Kuwahara Y: Lipocalin 2 enhances mesenchymal stem cell-based cell
therapy in acute kidney injury rat model. Cytotechnology.
70:103–117. 2018. View Article : Google Scholar :
|
|
173
|
Ni W, Zhang Y and Yin Z: The protective
mechanism of Klotho gene-modified bone marrow mesenchymal stem
cells on acute kidney injury induced by rhabdomyolysis. Regen Ther.
18:255–267. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Zhang J, Yuan Z, Zhong W and Wei Y: Stem
cell as vehicles of antibody in treatment of lymphoma: A novel and
potential targeted therapy. Stem Cell Rev Rep. 17:829–841. 2021.
View Article : Google Scholar
|
|
175
|
Chen Y, Qian H, Zhu W, Zhang X, Yan Y, Ye
S, Peng X, Li W and Xu W: Hepatocyte growth factor modification
promotes the amelioration effects of human umbilical cord
mesenchymal stem cells on rat acute kidney injury. Stem Cells Dev.
20:103–113. 2011. View Article : Google Scholar
|
|
176
|
Hagiwara M, Shen B, Chao L and Chao J:
Kallikrein-modified mesenchymal stem cell implantation provides
enhanced protection against acute ischemic kidney injury by
inhibiting apoptosivgs and inflammation. Hum Gene Ther. 19:807–819.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Liu N, Patzak A and Zhang J:
CXCR4-overexpressing bone marrow-derived mesenchymal stem cells
improve repair of acute kidney injury. Am J Physiol Renal Physiol.
305:F1064–F1073. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Liu N, Tian J, Cheng J and Zhang J:
Migration of CXCR4 gene-modified bone marrow-derived mesenchymal
stem cells to the acute injured kidney. J Cell Biochem.
114:2677–2689. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Liu N, Wang H, Han G, Cheng J, Hu W and
Zhang J: Enhanced proliferation and differentiation of HO-1
gene-modified bone marrow-derived mesenchymal stem cells in the
acute injured kidney. Int J Mol Med. 42:946–956. 2018.PubMed/NCBI
|
|
180
|
Liu N, Wang H, Han G, Tian J, Hu W and
Zhang J: Alleviation of apoptosis of bone marrow-derived
mesenchymal stem cells in the acute injured kidney by heme
oxygenase-1 gene modification. Int J Biochem Cell Biol. 69:85–94.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
181
|
da Cunha MGM, Zia S, Beckmann DV, Carlon
MS, Arcolino FO, Albersen M, Pippi NL, Graça DL, Gysemans C,
Carmeliet P, et al: Vascular endothelial growth factor
up-regulation in human amniotic fluid stem cell enhances
nephroprotection after ischemia-reperfusion injury in the rat. Crit
Care Med. 45:e86–e96. 2017. View Article : Google Scholar
|
|
182
|
Yuzeng Q, Weiyang H, Xin G, Qingson Z,
Youlin K and Ke R: Effects of transplantation with marrow-derived
mesenchymal stem cells modified with survivin on renal
ischemia-reperfusion injury in mice. Yonsei Med J. 55:1130–1137.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
183
|
Pawitan JA, Bui TA, Mubarok W, Antarianto
RD, Nurhayati RW, Dilogo IH and Oceandy D: Enhancement of the
therapeutic capacity of mesenchymal stem cells by genetic
modification: A systematic review. Front Cell Dev Biol.
8:5877762020. View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Kresse JC, Gregersen E, Atay JCL, Eijken M
and Nørregaard R: Does the route matter? A preclinical review of
mesenchymal stromal cell delivery to the kidney. APMIS.
131:687–697. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Schrepfer S, Deuse T, Reichenspurner H,
Fischbein MP, Robbins RC and Pelletier MP: Stem cell
transplantation: The lung barrier. Transplant Proc. 39:573–576.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
186
|
Fischer UM, Harting MT, Jimenez F,
Monzon-Posadas WO, Xue H, Savitz SI, Laine GA and Cox CS Jr:
Pulmonary passage is a major obstacle for intravenous stem cell
delivery: The pulmonary first-pass effect. Stem Cells Dev.
18:683–692. 2009. View Article : Google Scholar
|
|
187
|
Schmuck EG, Koch JM, Centanni JM, Hacker
TA, Braun RK, Eldridge M, Hei DJ, Hematti P and Raval AN:
Biodistribution and clearance of human mesenchymal stem cells by
quantitative three-dimensional cryo-imaging after intravenous
infusion in a rat lung injury model. Stem Cells Transl Med.
5:1668–1675. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
188
|
Lalu MM, McIntyre L, Pugliese C, Fergusson
D, Winston BW, Marshall JC, Granton J and Stewart DJ; Canadian
Critical Care Trials Group: Safety of cell therapy with mesenchymal
stromal cells (SafeCell): A systematic review and meta-analysis of
clinical trials. PLoS One. 7:e475592012. View Article : Google Scholar : PubMed/NCBI
|
|
189
|
Kansu E: Thrombosis in stem cell
transplantation. Hematology. 17(Suppl 1): S159–S162. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
190
|
Cui LL, Kerkelä E, Bakreen A, Nitzsche F,
Andrzejewska A, Nowakowski A, Janowski M, Walczak P, Boltze J,
Lukomska B and Jolkkonen J: The cerebral embolism evoked by
intra-arterial delivery of allogeneic bone marrow mesenchymal stem
cells in rats is related to cell dose and infusion velocity. Stem
Cell Res Ther. 6:112015. View Article : Google Scholar : PubMed/NCBI
|
|
191
|
Sanchez-Diaz M, Quiñones-Vico MI, de la
Torre RS, Montero-Vílchez T, Sierra-Sánchez A, Molina-Leyva A and
Arias-Santiago S: Biodistribution of mesenchymal stromal cells
after administration in animal models and humans: A systematic
review. J Clin Med. 10:29252021. View Article : Google Scholar : PubMed/NCBI
|
|
192
|
Bagno LL, Salerno AG, Balkan W and Hare
JM: Mechanism of Action of Mesenchymal Stem Cells (MSCs): Impact of
delivery method. Expert Opin Biol Ther. 22:449–463. 2022.
View Article : Google Scholar :
|
|
193
|
Kim K, Bou-Ghannam S, Kameishi S, Oka M,
Grainger DW and Okano T: Allogeneic mesenchymal stem cell sheet
therapy: A new frontier in drug delivery systems. J Control
Release. 330:696–704. 2021. View Article : Google Scholar
|
